These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15829251)

  • 1. Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus.
    Moroni F; Cozzi A; Carpendo R; Cipriani G; Veneroni O; Izzo E
    Neuropharmacology; 2005 May; 48(6):788-95. PubMed ID: 15829251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys.
    Samadi P; Grégoire L; Rassoulpour A; Guidetti P; Izzo E; Schwarcz R; Bédard PJ
    Mov Disord; 2005 Jul; 20(7):792-802. PubMed ID: 15954116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenine 3-hydroxylase inhibition in rats: effects on extracellular kynurenic acid concentration and N-methyl-D-aspartate-induced depolarisation in the striatum.
    Urenjak J; Obrenovitch TP
    J Neurochem; 2000 Dec; 75(6):2427-33. PubMed ID: 11080194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage.
    Moroni F; Carpenedo R; Cozzi A; Meli E; Chiarugi A; Pellegrini-Giampietro DE
    Adv Exp Med Biol; 2003; 527():127-36. PubMed ID: 15206725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase.
    Röver S; Cesura AM; Huguenin P; Kettler R; Szente A
    J Med Chem; 1997 Dec; 40(26):4378-85. PubMed ID: 9435907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.
    Carpenedo R; Meli E; Peruginelli F; Pellegrini-Giampietro DE; Moroni F
    J Neurochem; 2002 Sep; 82(6):1465-71. PubMed ID: 12354294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum.
    Okuno A; Fukuwatari T; Shibata K
    J Neurochem; 2011 Sep; 118(5):796-805. PubMed ID: 21711351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.
    Grégoire L; Rassoulpour A; Guidetti P; Samadi P; Bédard PJ; Izzo E; Schwarcz R; Di Paolo T
    Behav Brain Res; 2008 Jan; 186(2):161-7. PubMed ID: 17868931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat.
    Rassoulpour A; Wu HQ; Albuquerque EX; Schwarcz R
    Neuropsychopharmacology; 2005 Apr; 30(4):697-704. PubMed ID: 15496939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of exocytosis mechanisms of DOPA in rat striatum using in vivo microdialysis.
    Zhu G; Okada M; Yoshida S; Hirose S; Kaneko S
    Neurosci Lett; 2004 Sep; 367(2):241-5. PubMed ID: 15331162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
    Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
    Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of the substrate inhibitor l-trans-pyrrolidine-2,4-dicarboxylate (PDC) and the non-substrate inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) of glutamate transporters on neuronal damage and extracellular amino acid levels in rat brain in vivo.
    Montiel T; Camacho A; Estrada-Sánchez AM; Massieu L
    Neuroscience; 2005; 133(3):667-78. PubMed ID: 15890455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
    Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
    Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid.
    Schwieler L; Erhardt S; Nilsson L; Linderholm K; Engberg G
    Synapse; 2006 Apr; 59(5):290-8. PubMed ID: 16416446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of kynurenic acid synthesis in C6 glioma cells.
    Kocki T; Dolińska M; Dybel A; Urbańska EM; Turski WA; Albrecht J
    J Neurosci Res; 2002 Jun; 68(5):622-6. PubMed ID: 12111852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia.
    Cozzi A; Carpenedo R; Moroni F
    J Cereb Blood Flow Metab; 1999 Jul; 19(7):771-7. PubMed ID: 10413032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo.
    Beggiato S; Antonelli T; Tomasini MC; Tanganelli S; Fuxe K; Schwarcz R; Ferraro L
    Eur J Neurosci; 2013 May; 37(9):1470-7. PubMed ID: 23442092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
    Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
    Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of local perfusion of DAMGO on extracellular GABA and glutamate concentrations in the rostral ventromedial medulla.
    Schepers RJ; Mahoney JL; Zapata A; Chefer V; Shippenberg TS
    J Neurochem; 2008 Feb; 104(3):806-17. PubMed ID: 17961151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.